Top Performing Drugs of the Month - Keytruda
Active Ingredients: Pembrolizumab Strength: 100 mg/4 mL (25 mg/mL)...
Insights+: The US FDA New Drug Approvals in April 2022
The US FDA has approved 6 NDAs in Apr 2022, leading to treatments for patients and advances in the healthcare...
Insights+ Key Biosimilars Events of April 2022
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...
Top Performing Drugs of the Month - Humira
Active Ingredients: Adalimumab Strength: 40 mg/0.8 ml D...
Top Performing Prescription Drugs of 2021: A Monthly Series by PharmaShots
The year 2021 witnessed the global approval of vaccines and drugs amid COVID-19. The disease has been dominating the...
Insights+: The US FDA New Drug Approvals in March 2022
The US FDA has approved 9 NDAs and 1 BLAs in Mar 2022, leading to treatments for patients and advances in the...
